Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Identify which credit cards offer cash rewards without annual fees. This helps you keep your finances in check while earning rewards.
26,053 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
April brought a notable rally for Plug Power. This piece breaks down the forces behind the surge, what it signals for...
RH has endured a steep decline over five years. This article breaks down whether the luxury home brand can stage a re...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
As Micron gears up for its June earnings, a fresh investing angle centers on the idea that prediction: micron stock w...
As the Q4 2025 earnings season unfolds, savvy investors turn to transcripts to separate sound bites from real signal....
Lime, the e-scooter and e-bike maker backed by Uber, aims for a 2026 IPO, even as mounting debt and a tighter funding...
Small-cap stocks are drawing attention as they surge alongside big-name AI leaders. This article breaks down the driv...
Speculative growth stocks Archer Aviation and Quantum Computing slid after earnings, as burn rates and macro headwind...
Nebius Group stock rocketing has traders buzzing. This guide breaks down the momentum, explains the drivers, and offe...
Amazon often grabs attention with big growth and bold innovations. This guide helps you pause, assess the real risks,...